METHOD OF COMBINATION THERAPY OF BRONCHIAL ASTHMA Russian patent published in 2011 - IPC A61N5/67 A61N2/00 A61K31/573 A61P11/06 

FIELD: medicine.

SUBSTANCE: invention refers to medicine, pulmonology, and can be used for combination therapy of bronchial asthma. That is ensured by drug-induced therapy, supravenous blood laser irradiation and infrared magnetic-laser therapy (IR-MLT) of a projection area of adrenal glands The supravenous blood laser irradiation is carried out for 15 minutes at wave length 0.63 mcm, power 5 mWt by a light guide tip. The first and fifth IR-MLT procedures are preceded by examining cortisol and estradiol levels in females and testosterone level in males. If the cortisol level is lower than 230 nmol/l, and the testosterone level is lower than 500 ng/dl in males, and the estradiol level is lower than 30 pg/ml in non-menopause females and lower than 15 pg/ml in menopause females, pulse repetition rate is specified 150 Hz and "НМП" - 50 mT. If the cortisol level is 230 to 750 nmol/l, the estradiol level is 30 pg/ml to 160 pg/ml in females, and the testosterone level 260 to 1593 ng/dl in males, pulse repetition rate is specified 80 Hz and "НМЛ" 25 mT. Total exposure time for one session is no more than 18 minutes. The therapeutic course is 10-12 procedures.

EFFECT: method allows higher clinical effectiveness, reduced time of treatment, eliminates side effects, corrects the hormone level and allows reducing a dosage of the prescribed preparations.

1 tbl, 2 ex